Robert G.

Robert G. has extensive experience in the biopharmaceutical industry, currently serving as the Senior Director of Asset Development and Portfolio Management for the Alzheimer’s Disease Franchise at Biogen since May 2007. In this role, Robert oversees the Joint Partnership Pharmaceutical Operations and Technology Team, focusing on lifecycle management and strategic development. Prior positions at Biogen include Head of Biosimilars, where responsibilities involved establishing a comprehensive development and commercialization model, and roles in asset management for both the Alzheimer’s and SPINRAZA programs. Robert has also managed global product quality for gene therapy and biosimilars ventures, emphasizing regulatory compliance and quality systems design. Early career experience includes leading downstream process development initiatives at EMD Serono, enhancing efficiency in biologics manufacturing. Robert holds an MBA from the Questrom School of Business at Boston University and a BS in Biochemistry from Northeastern University.